Edgewise Therapeutics EWTX Income Statement (2024-2026)

NASDAQ EWTX
$46.69 -2.05 (-4.21%)
As of: Nov 10, 2026 · 2:57 PM EST
Reported Financials

Edgewise Therapeutics Quarterly Income Statement

Periods 10 quarters
Latest Sep 2026

Edgewise Therapeutics reported revenue of $16.50M and net income of $1166.15M for the quarter ended Sep 2026, up 154.0% year over year. This income statement covers 10 quarters of results from Mar 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Edgewise Therapeutics Income Statement API

Pull Edgewise Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EWTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY